- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01849302
The Effect of Beverages Varying in Protein Quantity on Appetite and Energy Intake
The Acute Effect of Beverages Varying in Macro-nutrient Content on Subjective Appetite Ratings and ad Libitum Energy Intake in Healthy Subjects
Over the last decades, changes in the diet and lifestyle have led to overall energy imbalance becoming commonplace and the emergence of an obesity epidemic with more than 1.6 billion adults being overweight.
Consumption of foods that can affect appetite by increasing satiety could regulate the total energy intake and thus body weight. There is data suggesting that the macronutrient composition of the foods and especially protein content may have a potent role on satiety. However, it is difficult to pinpoint the optimum quantity needed to observe significant effects of protein on satiety.
The research project is dedicated to identify which food components [proteins, carbohydrates (CHO), fats] and the optimized protein quantity needed to accelerate satiation, suppress appetite and extend satiety until hunger appears again.
It is hypothesized that the consumption of protein-enriched meals will induce a reduction in hunger through the impact on gut hormones and peptides that are closely related to the short-term regulation of food intake.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Skane
-
Lund, Skane, Sweden, 221 00
- Department of Applied Nutrition and Food Chemistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy males and females
- Age range 18-50 years
- Normal weight and overweight people as classified by BMI:22-27.9 kg/m2 (inclusive).
- Weight stable (within 3 kg) two months prior to study inclusion
- Understanding English well and feeling comfortable speaking it
Exclusion Criteria:
- Dietary protein consumption >25% energy from protein
- Had surgery in the previous 12 months
- Have suffered a myocardial infarction or stroke at any time
- Suffer from any blood-clotting disorder or prescription of any medication affecting blood clotting
- Suffer from any metabolic disorders (e.g. diabetes, metabolic syndrome or hypertension)
- Any requirement to take long-term medication, especially those active on the gastro-intestinal tract or for cardio-vascular disease
- Any dietary restrictions or recently/currently on a weight reducing diet
- Irregular eating patterns or not regularly consuming breakfast
- Food allergies (e.g. milk protein allergies) or intolerances (e.g. lactose)
- Use of medication which affects food intake or behaviour (e.g. anti-depressants)
- Use of medication likely to affect taste, smell or appetite
- Eating restraint based on the three Factor Eating Questionnaire
- Use of any protein supplements
- A history of alcohol or drug misuse (the average daily number of units of alcohol considered as acceptable is 2-3 units women; 3-4 units men
- Smoking
- Athletes in training (>10 h exercise/week)
- Female that is breast-feeding, pregnant, or if of child-bearing potential and are not using effective contraceptive precautions
- Involvement in a study involving an experimental drug/medication within 3 months prior to entry of this study
- Blood pressure > 160/90 mmHg
- Vegan or Vegetarian
- Glucose > 6 mmol/L
- Gamma glutamyl transferase > 1.9 μkat / L
- Alanine transaminase > 1.1 μkat / L
- Cholesterol > 6.5 mmol/L
- Triglycerides > 2.0 mmol/L
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High protein/ High fat beverage
Beverage based on milk protein: 1.8 MJ, 40 E% Protein, 42 E% fat Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
|
Experimental: High protein/ Normal CHO beverage
Beverage based on milk protein: 1.8 MJ, 40 E% Protein, 47 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
|
Experimental: Low protein/ High fat beverage
Beverage based on milk protein: 1.8 MJ, 9 E% Protein, 63 E% fat Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
|
Experimental: Low protein/ High CHO beverage
Beverage based on milk protein: 1.8 MJ, 9 E% Protein, 71 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
|
Experimental: Normal protein/ Normal CHO beverage 1
Beverage based on milk protein: 1.8 MJ, 24 E% Protein, 50 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
|
Experimental: Normal protein/Normal CHO beverage 2
Beverage based on milk protein: 1.8 MJ, 24 E% Protein, 50 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
|
Experimental: Normal protein/Normal CHO beverage 3
Beverage based on milk protein: 1.8 MJ, 24 E% Protein, 50 E% CHO Acute effect of beverages varying in macronutrient content on appetite and energy intake |
In this randomized, within-subject study, subjects are asked to consume 7 iso-energetic and iso-volumetric beverages as breakfast (20% of estimated energy requirements) with varying distribution of macronutrients.
The objective is to identify the optimal protein quantity or macronutrient distribution on suppressing appetite.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes from baseline in perceived appetite and satiety
Time Frame: Assessed every 30 min for 270 min after each of the seven beverages which are served at least one week apart (7 weeks)
|
The appetite profile is assessed using validated Visual Analogue Scales (VAS) ratings (i.e hunger, fullness, desire to eat, prospective food consumption).
The Questionnaires are performed electronically in personal laptops using the Adaptive Visual Analogue Scales (AVAS) software.
|
Assessed every 30 min for 270 min after each of the seven beverages which are served at least one week apart (7 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ad libitum energy intake
Time Frame: Energy intake is assessed 210 min after the 7 test beverages, which are served one week apart.
|
Energy intake is assessed by ad libitum hot pasta meal provided 210 min after the test beverages, which are given as breakfast.
Subjects are instructed to eat only until they feel comfortable satisfied and are given 25min to consume the meal.
The total energy consumed is monitored
|
Energy intake is assessed 210 min after the 7 test beverages, which are served one week apart.
|
|
Changes from baseline in the postprandial concentration of satiety hormones
Time Frame: Assessed at 6 points in time over the morning of each of the 7 test days, which are separated by 1 week (7 weeks)
|
Blood samples (2 ml) are collected at 0 min (fasted blood sample), 30, 60, 90, 150 and 205 min (i.e. total of 6 samples) over the morning on each test day (separated by 1 week) to quantify the plasma concentrations of circulating appetite regulating hormones.
Protease inhibitors are added to the samples to reduce protein degradation.
All samples are centrifuged at 4 C for 10 min at 2000 g after collection and are separated and stored in cryogenic vials at -80 C.
|
Assessed at 6 points in time over the morning of each of the 7 test days, which are separated by 1 week (7 weeks)
|
|
Hedonic ratings and palatability of the test beverages and meals
Time Frame: Assessed immediately after consumption of the 7 test beverages and pasta meal (7 weeks)
|
The palatability and hedonic ratings are assessed using validated Visual Analogue Scales (VAS) ratings (i.e appearance, taste, overall palatability).
The Questionnaires are performed electronically in personal laptops using the Adaptive Visual Analogue Scales (AVAS) software.
|
Assessed immediately after consumption of the 7 test beverages and pasta meal (7 weeks)
|
|
Changes from baseline in the postprandial concentration of glucose
Time Frame: Assessed at 7 points in time over the morning of each of the 7 test days, which are separated by 1 week (7 weeks)
|
Capillary blood samples are collected by finger-prick at 0 min (fasted blood sample), 30, 45, 60, 90, 150 and 205 min (i.e. total of 7 samples) over the morning on each test day (separated by 1 week) to quantify the glucose concentration using HemoCue Glucose System.
|
Assessed at 7 points in time over the morning of each of the 7 test days, which are separated by 1 week (7 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Anestis Dougkas, PhD, Lund University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2012/6
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Beverages varying in macronutrient content on appetite
-
Lund UniversityCompleted
-
University of GuelphAgriculture and Agri-Food Canada; Saskatchewan Pulse Growers; Pulse CanadaCompleted
-
University of CopenhagenCompleted
-
Hacettepe UniversityCompletedEnergy Intake | Appetite | Post-exercise | Negative Energy BalanceTurkey (Türkiye)
-
Samsung Medical CenterNot yet recruiting
-
University of VermontNational Institute on Drug Abuse (NIDA); Johns Hopkins University; Food and Drug...CompletedTobacco Use DisorderUnited States
-
Medical University of ViennaCompletedSepsis | Healthy VolunteersAustria
-
Xi'an Hospital of Traditional Chinese MedicineCompletedColorectal Polyps | Modified SiNiSanChina
-
University of GaziantepCompletedExercise Performance | Physical PerformanceTurkey (Türkiye)